The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Open accessAbstract
Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation. RNA interference (RNAi)-based loss-of-function screening has proven powerful for the identification of new and interesting cancer targets, and recent studies have used this technology in vivo to identify novel tumour suppressor genes. Here we developed a method for identifying novel cancer targets via negative-selection RNAi screening using a human breast cancer xenograft model at an orthotopic site in the mouse. Using this method, we screened a set of metabolic genes associated with aggressive breast cancer and stemness to identify those required for in vivo tumorigenesis. Among the genes identified, phosphoglycerate dehydrogenase (PHGDH) is in a genomic region of recurrent copy number gain in breast cancer and PHGDH protein levels are elevated in 70% of oestrogen receptor (ER)-negative breast cancers. PHGDH catalyses the first step in the serine biosynthesis pathway, and breast cancer cells with high PHGDH expression have increased serine synthesis flux. Suppression of PHGDH in cell lines with elevated PHGDH expression, but not in those without, causes a strong decrease in cell proliferation and a reduction in serine synthesis. We find that PHGDH suppression does not affect intracellular serine levels, but causes a drop in the levels of α-ketoglutarate, another output of the pathway and a tricarboxylic acid (TCA) cycle intermediate. In cells with high PHGDH expression, the serine synthesis pathway contributes approximately 50% of the total anaplerotic flux of glutamine into the TCA cycle. These results reveal that certain breast cancers are dependent upon increased serine pathway flux caused by PHGDH overexpression and demonstrate the utility of in vivo negative-selection RNAi screens for finding potential anticancer targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Functional PHGDH loss is toxic to tumor cells with PHGDH amplification or high serine biosynthetic flux (Locasale et al., 2011; Mattaini et al., 2015; Possemato et al., 2011; Zhang et al., 2017), and small-molecule inhibitors targeting PHGDH have been shown to inhibit serine synthesis and tumor proliferation in vitro and in xenograft cancer models (Mullarky et al., 2016; Pacold et al., 2016; Wang”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“Serine is present in plasma and can be taken up by cells via amino acid transporters, yet PHGDH expression and increased serine biosynthesis have been shown to be important for supporting cancer cell proliferation and survival in both in vitro and in vivo settings (Locasale et al., 2011; Possemato et al., 2011).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“Increased PHGDH gene expression leads to greater production of serine from glucose and is associated with specific subsets of breast cancer, lung adenocarcinoma, and melanoma (Locasale et al., 2011; Possemato et al., 2011; Zhang et al., 2017).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“More recently, it was found that increased expression of the serine synthesis enzyme phosphoglycerate dehydrogenase (PHGDH) in some cancers can result from copy number gain of a region on chromosome 1p (Beroukhim et al., 2010; Locasale et al., 2011; Possemato et al., 2011) or a consequence of oncogenic signaling, including NRF2 and ATF4 signaling (DeNicola et al., 2015), or hypoxia responses (Sam”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“A rate-limiting serine biosynthesis enzyme, 3-phosphoglycerate dehydrogenase (PHGDH), is frequently focally amplified in breast cancer and melanoma and is required for the growth of PHGDH-amplified cells in vitro as well as in vivo”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Possemato et al., 2011
In the citing paper
“Amplification of PHGDH has been observed in breast cancer and melanoma (65), and increased PHGDH expression can promote both enhanced serine biosynthesis and the proliferation of cancer cells (65, 66).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [66]
In the citing paper
“the region of chromosome 1p12 encoding PHGDH is amplified in a significant fraction of tumors”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Possemato et al., 2011
In the citing paper
“cell lines derived from these tumors tend to be highly dependent on PHGDH expression”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Possemato et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,474
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Self-citationDeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.024 · Cited by 2,464
Self-citationCancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 2×
“Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation (1,2).”
Self-citationRhodes, D. R., Sundaram, S. K., Mahavisno, V., Varambally, R., Yu, J., Briggs, B., Barrette, T. R., Anstett, M. J., Kincead-Beal, C., Kulkarni, P., et al. (2007) · Neoplasia · doi:10.1593/neo.07112 · Cited by 2,057
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,804
Self-citationDissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J. H., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,515
Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells
Marson, A., Levine, S. S., Cole, M. F., Frampton, G. M., Brambrink, T., Johnstone, S. E., Guenther, M. G., Johnston, W. K., Wernig, M., Newman, J. J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.020 · Cited by 1,405
Cited by
Sorted by citations
Items 801–900 of 1,000
One carbon metabolism in human lung cancer
Yao, S., Peng, L., Elakad, O., Küffer, S., Hinterthaner, M., Danner, B. C., von Hammerstein-Equord, A. F., Ströbel, P., & Bohnenberger, H. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-1039 · Cited by 35
Amino acid metabolic reprogramming in tumor metastatic colonization
Wang, Z., Wu, X., Chen, H., & Wang, K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1123192 · Cited by 35
A primer on using pooled shRNA libraries for functional genomic screens
Hu, G., & Luo, J. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr116 · Cited by 35
Correlation Factors Analysis of Breast Cancer Tumor Volume Doubling Time Measured by 3D-Ultrasound
Zhang, S., Ding, Y., Zhou, Q., Wang, C., Peng-xi, W., & Dong, J. (2017) · Medical Science Monitor · doi:10.12659/msm.901566 · Cited by 35
Warburg and Krebs and related effects in cancer
Unterlass, J. E., & Curtin, N. J. (2019) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2019.4 · Cited by 35
The unique catalytic properties of PSAT1 mediate metabolic adaptation to glutamine blockade
Qiu, Y., Stamatatos, O. T., Hu, Q., Swain, J. D. R., Russo, S., Sann, A., Costa, A. S. H., Violante, S. N., Spector, D. L., Cross, J. R., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01104-w · Cited by 34
Decoding key nodes in the metabolism of cancer cells: sugar & spice and all things nice
Cantley, L., & Shaw, R. (2011) · F1000 Biology Reports · doi:10.3410/b4-2 · Cited by 34
Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer
Wu, H. J., Xian, Y., Zhang, S., Wang, X., Jin, Q., & Wang, W. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s105787 · Cited by 34
Overcoming Radiation Resistance in Gliomas by Targeting Metabolism and DNA Repair Pathways
Meng, W., Palmer, J. D., Siedow, M. R., Haque, S. J., & Chakravarti, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042246 · Cited by 34
Sekar, D., Dillmann, C., Sirait-Fischer, E., Fink, A. F., Živković, A., Baum, N., Strack, E., Klatt, S., Zukunft, S., Wallner, S., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-20-3870 · Cited by 34
Ünlü, G., Prizer, B., Erdal, R., Yeh, H.-W., Bayraktar, E. C., & Birsoy, K. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.05.024 · Cited by 34
Self-citationSemeniuk-Wojtaś, A., Poddębniak-Strama, K., Modzelewska, M., Baryła, M., Dziąg-Dudek, E., Syryło, T., Górnicka, B., Jakieła, A., & Stec, R. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03376-9 · Cited by 34
Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
Murali, R., Balasubramaniam, V., Srinivas, S., Sundaram, S., Venkatraman, G., Warrier, S. R., Dharmarajan, A., & Gandhirajan, R. K. (2023) · Metabolites · doi:10.3390/metabo13040560 · Cited by 34
SIRT6 Puts Cancer Metabolism in the Driver’s Seat
Lyssiotis, C. A., & Cantley, L. C. (2012) · Cell · doi:10.1016/j.cell.2012.11.020 · Cited by 34
Zhang, J., Wei, H., Aiping, D., Qi, Y., & Shulan, Z. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e3182a0c068 · Cited by 34
Zhang, W., Wei, Y., Ignatchenko, V., Li, L., Sakashita, S., Pham, N., Taylor, P. P., Tsao, M., Kislinger, T., & Moran, M. F. (2014) · PROTEOMICS · doi:10.1002/pmic.201300382 · Cited by 34
Colitis-accelerated colorectal cancer and metabolic dysregulation in a mouse model
Gao, Y., Li, X., Yang, M. W., Zhao, Q., Liu, X., Wang, G., Lü, X., Wu, Q., Wu, J., Yang, Y., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt135 · Cited by 34
Linden, C. V., & Corbet, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.016 · Cited by 34
Nf1 loss promotes Kras-driven lung adenocarcinoma and results in Psat1-mediated glutamate dependence
Wang, X., Min, S., Liu, H., Wu, N., Liu, X., Wang, T., Li, W., Shen, Y., Wang, H., Qian, Z., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809856 · Cited by 33
From gametogenesis and stem cells to cancer: common metabolic themes
Pereira, S. L., Rodrigues, A. S., Sousa, M. I., Correia, M., Perestrelo, T., & Ramalho‐Santos, J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu034 · Cited by 33
Metabolic Regulation in Mitochondria and Drug Resistance
Pan, Y., Cao, M., Liu, J., Yang, Q. K., Miao, X., Go, V. L. W., Lee, P. W. N., & Xiao, G. G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6674-0_11 · Cited by 33
Potassium and Sodium Channels and the Warburg Effect: Biophysical Regulation of Cancer Metabolism
Iorio, J., Petroni, G., Duranti, C., & Lastraioli, E. (2019) · Bioelectricity · doi:10.1089/bioe.2019.0017 · Cited by 33
Seifried, A., Knobloch, G., Duraphe, P. S., Segerer, G., Manhard, J., Schindelin, H., Schultz, J., & Gohla, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.503359 · Cited by 33
The Role of Fatty Acid Oxidation in the Metabolic Reprograming of Activated T-Cells
Byersdorfer, C. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00641 · Cited by 33
Energy and Redox Homeostasis in Tumor Cells
de Oliveira, M. F., Amoêdo, N. D., & Rumjanek, F. D. (2012) · International Journal of Cell Biology · doi:10.1155/2012/593838 · Cited by 33
Synthetic lethal approaches for assessing combinatorial efficacy of chemotherapeutic drugs
Jackson, R. A., & Chen, E. S. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.014 · Cited by 33
Frezza, C. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2086 · Cited by 33
Luo, W., Zou, Z., Nie, Y., Luo, J., Ming, Z., Hu, X., Luo, T., Ouyang, M., Mingquan, L., Tang, H., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06672-z · Cited by 32
Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities
Liu, Y., Zong, X., Altea‐Manzano, P., & Fu, J. (2025) · Protein & Cell · doi:10.1093/procel/pwaf011 · Cited by 32
Expression reflects population structure
Brown, B. C., Bray, N., & Pachter, L. S. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007841 · Cited by 32
Brearley-Sholto, M. C., Li, C., Daniel, Z. C. T. R., Loughna, P. T., Parr, T., & Brameld, J. M. (2019) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2019.100694 · Cited by 32
PHGDH supports liver ceramide synthesis and sustains lipid homeostasis
Kang, Y. P., Falzone, A., Liu, M., González‐Sánchez, P., Choi, B.-H., Coloff, J. L., Saller, J. J., Karreth, F. A., & DeNicola, G. M. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00212-x · Cited by 32
Li, M., Liu, L., Zhang, W., Zhan, H., Chen, R., Feng, J., & Wu, L. (2020) · Oncology Reports · doi:10.3892/or.2020.7754 · Cited by 32
Phosphoglycerate dehydrogenase (PHGDH) inhibitors: a comprehensive review 2015–2020
Spillier, Q., & Frédérick, R. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1890028 · Cited by 32
Specific activation of glycolytic enzyme enolase 2 in BRAF V600E‐mutated colorectal cancer
Yukimoto, R., Nishida, N., Hata, T., Fujino, S., Ogino, T., Miyoshi, N., Takahashi, H., Uemura, M., Satoh, T., Yamamoto, H., et al. (2021) · Cancer Science · doi:10.1111/cas.14929 · Cited by 32
Duan, Y., Li, J., Wang, F., Wei, J., Yang, Z., Sun, M., Liu, J., Wen, M., Huang, W., Chen, Z., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110137 · Cited by 32
The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment
Zhou, X., Tian, C., Cao, Y., Zhao, M., & Wang, K. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1084609 · Cited by 32
Cancer metabolomics in basic science perspective
Kwon, H. N., Oh, S., Jin, X., An, Y., & Park, S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0552-4 · Cited by 32
The metabolomic signature of hematologic malignancies
Allegra, A., Innao, V., Gerace, D. G., Bianco, O., & Musolino, C. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.08.002 · Cited by 32
Issaq, S. H., Mendoza, A., Kidner, R. Q., Rosales, T. I., Duveau, D. Y., Heske, C. M., Rohde, J. M., Boxer, M. B., Thomas, C. J., DeBerardinis, R. J., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0748 · Cited by 32
Yoshino, H., Enokida, H., Osako, Y., Nohata, N., Yonemori, M., Sugita, S., Kuroshima, K., Tsuruda, M., Tatarano, S., & Nakagawa, M. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12697 · Cited by 32
Thermodynamic constraints on the regulation of metabolic fluxes
Dai, Z., & Locasale, J. W. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004372 · Cited by 31
Metabolism-Associated Molecular Classification of Colorectal Cancer
Zhang, M., Wang, H., Peng, R., Xu, F., Wang, F., & Zhao, Q. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.602498 · Cited by 31
ASCT2 is a major contributor to serine uptake in cancer cells
Conger, K. O., Chidley, C., Özgürses, M. E., Zhao, H., Kim, Y., Semina, S. E., Burns, P., Rawat, V., Lietuvninkas, L., Sheldon, R. D., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114552 · Cited by 31
Glutamine, Glucose and other Fuels for Cancer
Ruiz-Pérez, M. V., Sánchez‐Jiménez, F., Alonso, F. J., Segura, J., Márquez, J., & Medina, M. Á. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990482 · Cited by 31
Metabolomics—A Promising Approach to Pituitary Adenomas
Stănoiu-Pînzariu, O., Georgescu, B., & Georgescu, C. E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00814 · Cited by 31
Kujundžić, R. N., Stepanić, V., Milković, L., Gašparović, A. Č., Tomljanović, M., & Gall‐Tros̆elj, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051180 · Cited by 31
Lagziel, S., Lee, W. D., & Shlomi, T. (2019) · BMC Biology · doi:10.1186/s12915-019-0669-x · Cited by 31
Toxico‐Metabolomics of Engineered Nanomaterials: Progress and Challenges
Ahmad, F., Wang, X., & Li, W. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201904268 · Cited by 31
Zhang, Y., Zhang, R., Liang, F., Zhang, L., & Liang, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.598801 · Cited by 32
Jiang, P., Sun, W., Shen, N., Huang, X., & Fu, S. (2020) · BMC Cancer · doi:10.1186/s12885-020-07345-8 · Cited by 30
Khan, A., Siddiqui, S. I., Husain, S. A., Mazurek, S., & Iqbal, M. A. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c01173 · Cited by 29
Extracellular serine empowers epidermal proliferation and psoriasis-like symptoms
Cappello, A., Mancini, M., Madonna, S., Rinaldo, S., Paone, A., Scarponi, C., Belardo, A., Zolla, L., Zuccotti, A., Panatta, E., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm7902 · Cited by 30
Transcription factor NKX2–1 drives serine and glycine synthesis addiction in cancer
Heylen, E., Verstraete, P., Aerschot, L. V., Geeraerts, S. L., Venken, T., Timcheva, K., Nittner, D., Verbeeck, J., Royaert, J., Gijbels, M. J., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02216-y · Cited by 30
Chen, J., Ye, C., Yang, Z., Zhang, C., Li, P., Bing, X., Wu, A., Zhang, X., & Xue, X. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154808 · Cited by 30
Yin, K. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s82433 · Cited by 30
Hu, Y., Qi, Y., Liu, H., Fan, G., & Chai, Y. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.024 · Cited by 30
Identification of metabolism-related subtypes and feature genes in Alzheimer’s disease
Lian, P., Cai, X., Wang, C., Liu, K., Yang, X., Wu, Y., Zhang, Z., Ma, Z., Cao, X., & Xu, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04324-y · Cited by 29
Huang, S., Chan, Y., Huang, S., & Lin, Y. (2019) · Cancers · doi:10.3390/cancers12010013 · Cited by 29
Long non-coding RNAs affecting cell metabolism in cancer
Agostini, M., Mancini, M., & Candi, E. (2022) · Biology Direct · doi:10.1186/s13062-022-00341-x · Cited by 29
Jekabsons, M. B., Merrell, M., Skubiz, A. G., Thornton, N., Milasta, S., Green, D. R., Chen, T., Wang, Y., Avula, B., Khan, I. A., et al. (2023) · Cancer & Metabolism · doi:10.1186/s40170-023-00303-5 · Cited by 29
Pan, Q., Yu, F., Jin, H., Zhang, P., Huang, X., Peng, J., Xie, X., Li, X., Ma, N., Yue, W., et al. (2023) · Advanced Science · doi:10.1002/advs.202300759 · Cited by 29
Mariño‐Enríquez, A., Ou, W.-B., Cowley, G. S., Luo, B., Jonker, A. H., Mayeda, M., Okamoto, M., Eilers, G., Czaplinski, J. T., Sicińska, E., et al. (2013) · Oncogene · doi:10.1038/onc.2013.127 · Cited by 29
Self-citationMetabolic implication of tumor:stroma crosstalk in breast cancer
Morandi, A., & Chiarugi, P. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1124-7 · Cited by 29
Analysis of Host Gene Expression Profile in HIV-1 and HIV-2 Infected T-Cells
Devadas, K., Biswas, S., Setty, M. K. H. G., Wood, O., Ragupathy, V., Lee, S., & HEWLETT, I. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147421 · Cited by 29
Disease monitoring of hepatocellular carcinoma through metabolomics
Fitian, A. I., & Cabrera, R. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i1.1 · Cited by 29
Metabolic rewiring of pancreatic ductal adenocarcinoma: New routes to follow within the maze
Olivares, O., & Vasseur, S. (2015) · International Journal of Cancer · doi:10.1002/ijc.29501 · Cited by 28
Comparative analysis ofTsc1andTsc2single and double radial glial cell mutants
Mietzsch, U., McKenna, J. T., Reith, R. M., Way, S. W., & Gambello, M. J. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23380 · Cited by 28
HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell
Valentin-Guillama, G. A., Acevedo, S. N. L., Kucheryavykh, Y. V., Chorna, N., Pérez, J., Ortiz-Rivera, J., Inyushin, M. Y., Makarov, V. I., Valentín-Acevedo, A., Quiñones‐Hinojosa, A., et al. (2018) · Cancers · doi:10.3390/cancers10090301 · Cited by 28
Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer
Zhao, X., Fu, J., Hu, B., Chen, L., Wang, J., Fang, J., Ge, C., Lin, H., Pan, K., Fu, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639111 · Cited by 28
Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells
Wang, J., Filippakis, H., Hougard, T. R., Du, H., Ye, C., Liu, H.-J., Zhang, L., Hindi, K. M., Bagwe, S., Nijmeh, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2101268118 · Cited by 28
Xiao, Q., Yu, F., Yan, L., Zhao, H., & Zhang, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1026070 · Cited by 28
ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC
Wang, H., Lin, F., Xu, Z., Yu, S., Li, G., Liao, S., Zhao, W., Zhang, F., Wang, J., Wang, S., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.06.006 · Cited by 28
Cui, B., He, B., Huang, Y., Wang, C., Luo, H., Lü, J., Su, K., Zhang, X., Luo, Y., Zhao, Z., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06200-5 · Cited by 28
Anoman, A. D., Flores‐Tornero, M., Rosa‐Téllez, S., Muñoz‐Bertomeu, J., Segura, J., & Ros, R. (2016) · Plant Signaling & Behavior · doi:10.1080/15592324.2015.1128614 · Cited by 28
Otto, A. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.596197 · Cited by 28
PHGDH activation fuels glioblastoma progression and radioresistance via serine synthesis pathway
Liu, X., Liu, B., Wang, J., Liu, H., Wu, J., Qi, Y., Liu, Y., Zhu, H., Li, C., Liu, Y., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03361-3 · Cited by 27
A novel small-molecule inhibitor of 3-phosphoglycerate dehydrogenase
Mullarky, E., Lairson, L. L., Cantley, L. C., & Lyssiotis, C. A. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2016.1164280 · Cited by 27
Park, S., Seo, E.-H., Bae, D.-H., Kim, S. S., Kim, J., Lin, W., Kim, K., Park, J. B., Kim, S., Yin, J., et al. (2019) · PubMed Central · doi:10.14348/molcells.2019.0160 · Cited by 27
The nexus between redox state and intermediary metabolism
Zoccarato, A., Nabeebaccus, A., Oexner, R. R., Santos, C. X. C., & Shah, A. M. (2021) · FEBS Journal · doi:10.1111/febs.16191 · Cited by 27
Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer
Corchado‐Cobos, R., García‐Sancha, N., Mendiburu‐Eliçabe, M., Gómez-Vecino, A., Jiménez‐Navas, A., Pérez‐Baena, M. J., Holgado-Madruga, M., Mao, J., Cañueto, J., Castillo‐Lluva, S., et al. (2022) · Cancers · doi:10.3390/cancers14020322 · Cited by 27
Serine starvation silences estrogen receptor signaling through histone hypoacetylation
Li, A. M., He, B., Karagiannis, D., Li, Y., Jiang, H., Srinivasan, P., Ramirez, Y., Zhou, M.-N., Curtis, C. N., Gruber, J. J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302489120 · Cited by 27
Optimal energy and redox metabolism in the cyanobacterium Synechocystis sp. PCC 6803
Kugler, A., & Stensjö, K. (2023) · npj Systems Biology and Applications · doi:10.1038/s41540-023-00307-3 · Cited by 27
Spillier, Q., Ravez, S., Unterlass, J. E., Corbet, C., Degavre, C., Féron, O., & Frédérick, R. (2020) · Pharmaceuticals · doi:10.3390/ph13020020 · Cited by 27
Yang, D., Yang, X., Li, Y., Zhao, P., Fu, R., Ren, T., Hu, P., Wu, Y., Yang, H., & Guo, N. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02401-0 · Cited by 27
Intermediary metabolism: An intricate network at the crossroads of cell fate and function
Ferreira, L. M. R., Li, A. M., Serafim, T. L., Sobral, M. C. M., Alpoim, M. C., & Urbano, A. M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165887 · Cited by 27
A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma
Amjad, E., Pezzani, R., & Sokouti, B. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.044473 · Cited by 26
Tian, S., Feng, J., Cao, Y., Shen, S., Cai, Y., Yang, D., Yan, R., Wang, L., Zhang, H., Zhong, X., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900413 · Cited by 26
Wang, Z., Embaye, K. S., Yang, Q., Qin, L., Zhang, C., Liu, L., Zhan, X., Zhang, F., Wang, X., & Qin, S. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s294108 · Cited by 26
Targeting Nutrient Dependency in Cancer Treatment
Fan, K., Liu, Z., Gao, M., Tu, K., Xu, Q., & Zhang, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.820173 · Cited by 26
Zhu, S., Wang, X., Liu, L., & Ren, G. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101399 · Cited by 26
Dietary Manipulation of Amino Acids for Cancer Therapy
Jiménez‐Alonso, J. J., & López‐Lázaro, M. (2023) · Nutrients · doi:10.3390/nu15132879 · Cited by 26
Reprogramming of urea cycle in cancer: Mechanism, regulation and prospective therapeutic scopes
Ghosh, N., Mahalanobish, S., & Sil, P. C. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116326 · Cited by 26
Metabolic heterogeneity signature of primary treatment-naïve prostate cancer
Lin, D., Ettinger, S., Qu, S., Xue, H., Nabavi, N., Choi, S. Y. C., Bell, R. H., Mo, F., Haegert, A. M., Gout, P. W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15237 · Cited by 26
Dai, Z., Xu, L., Xu, L., Liao, K., Deng, S., Chen, Q., Wang, Q., Wang, Q., Gao, S., Li, B., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0439-y · Cited by 26
Metabolism in the Tumor Microenvironment
Montenegro, F., & Indraccolo, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-44518-8_1 · Cited by 26
Targeting phosphoglycerate dehydrogenase in multiple myeloma
Elsaadi, S., Steiro, I. J., Abdollahi, P., Vandsemb, E. N., Yang, R. R., Slørdahl, T. S., Rø, T. B., Menu, E., Sponaas, A., & Børset, M. (2021) · Experimental Hematology and Oncology · doi:10.1186/s40164-020-00196-w · Cited by 26
Mäntyselkä, S., Kolari, K., Baumert, P., Ylä-Outinen, L., Kuikka, L., Lahtonen, S., Permi, P., Wackerhage, H., Kalenius, E., Kivelä, R., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00151.2023 · Cited by 25
Fructose metabolism and its roles in metabolic diseases, inflammatory diseases, and cancer
Li, Z., Fan, X., Gao, F., Pan, S., Ma, X., Cheng, H., Nakatsukasa, H., Zhang, W., & Zhang, D. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00287-2 · Cited by 25
Shi, H., Fang, X., Li, Y., & Zhang, Y. (2019) · Medical Science Monitor · doi:10.12659/msm.917435 · Cited by 25
Metadata
- Authors
- Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., Chen, W. W., Barrett, F. G., Stransky, N., Tsun, Z.-Y., Cowley, G. S., Barretina, J., Kalaany, N. Y., Hsu, P. P., Ottina, K., Chan, A. M., Yuan, B., Garraway, L. A., Root, D. E., Mino-Kenudson, M., Brachtel, E. F., Driggers, E. M., & Sabatini, D. M.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Agios Pharmaceuticals (United States) (US)
- Broad Institute (US)
- Harvard University (US)
- Corresponding author
- Sabatini, David M.
- ORCID
- Possemato, Richard
- Shaul, Yoav D.
- Pacold, Michael E.
- Kim, Dohoon
- Birsoy, Kıvanç
- Sethumadhavan, Shalini
- Jang, Hyun G.
- Jha, Abhishek K.
- Chen, Walter W.
- Barrett, Francesca G.
- Stransky, Nicolas
- Cowley, Glenn S.
- Barretina, Jordi
- Kalaany, Nada Y.
- Hsu, Peggy P.
- Yuan, Bingbing
- Garraway, Levi A.
- Root, David E.
- Mino-Kenudson, Mari
- Brachtel, Elena F.
- Sabatini, David M.
- Venue
- Nature
- Published
- 2011-08
- Volume
- 476
- Issue
- 7360
- Pages
- 346-350
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3353325
- OpenAlex
- W2022899908
- Cited by
- 1,683
- References
- 27
- Citations by year
- 2026: 72 · 2025: 111 · 2024: 120 · 2023: 116 · 2022: 138 · 2021: 167 · 2020: 137 · 2019: 126 · 2018: 93 · 2017: 97 · 2016: 125 · 2015: 93 · 2014: 109 · 2013: 72 · 2012: 87
- FWCI
- 31.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- RePEc: Research Papers in Economics (submittedVersion)
- PMC
- Funders
- Howard Hughes Medical Institute
- W. M. Keck Foundation
- Alexander and Margaret Stewart Trust
- Life Sciences Research Foundation
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- National Institutes of Health
- National Cancer Institute (CA103866, R01CA103866, R01CA129105)
- National Institute of General Medical Sciences (T32GM007753)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- PHGDH, breast cancer, cancer metabolism, breast cancer xenografts, estrogen receptor-negative breast cancer, alpha-ketoglutarate, glutamine metabolism, TCA cycle, anaplerosis, tumor metabolic reprogramming, anticancer drug targets, cell proliferation
- MeSH terms
- Animals, Breast Neoplasms, Citric Acid Cycle, Humans, Ketoglutaric Acids, Melanoma, Neoplasm Transplantation, Serine, Biomarkers, Tumor, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Glutamic Acid, Genomics, RNA Interference, Cell Line, Tumor, Cell Proliferation, Phosphoglycerate Dehydrogenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
